CALO', Valentina
 Distribuzione geografica
Continente #
NA - Nord America 7.648
EU - Europa 3.983
AS - Asia 2.925
SA - Sud America 485
Continente sconosciuto - Info sul continente non disponibili 305
AF - Africa 61
OC - Oceania 4
Totale 15.411
Nazione #
US - Stati Uniti d'America 7.487
SG - Singapore 1.025
RU - Federazione Russa 892
CN - Cina 821
IT - Italia 675
DE - Germania 619
FI - Finlandia 604
BR - Brasile 372
HK - Hong Kong 285
VN - Vietnam 252
UA - Ucraina 241
GB - Regno Unito 219
PL - Polonia 149
FR - Francia 130
IE - Irlanda 125
JP - Giappone 109
SE - Svezia 101
IN - India 82
CA - Canada 79
KR - Corea 74
BE - Belgio 66
BD - Bangladesh 65
AR - Argentina 36
TR - Turchia 35
NL - Olanda 33
MX - Messico 32
IQ - Iraq 29
AT - Austria 25
IR - Iran 25
RO - Romania 24
CO - Colombia 21
ES - Italia 19
EC - Ecuador 17
CR - Costa Rica 15
CZ - Repubblica Ceca 15
VE - Venezuela 15
ID - Indonesia 13
MY - Malesia 13
TN - Tunisia 13
UZ - Uzbekistan 12
ZA - Sudafrica 12
PK - Pakistan 10
SA - Arabia Saudita 10
CH - Svizzera 9
CI - Costa d'Avorio 8
JM - Giamaica 7
LB - Libano 7
MA - Marocco 7
NP - Nepal 7
PH - Filippine 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
GR - Grecia 6
LT - Lituania 6
AZ - Azerbaigian 5
DZ - Algeria 5
KE - Kenya 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
HU - Ungheria 4
KZ - Kazakistan 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
NI - Nicaragua 3
OM - Oman 3
PT - Portogallo 3
AM - Armenia 2
BB - Barbados 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
DM - Dominica 1
FJ - Figi 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
Totale 15.094
Città #
Ashburn 899
Fairfield 667
Singapore 649
San Jose 553
Woodbridge 399
Chandler 393
Ann Arbor 353
Houston 341
Wilmington 316
Seattle 288
Hong Kong 276
Cambridge 231
Palermo 196
Moscow 170
New York 138
Council Bluffs 128
Dublin 124
Jacksonville 124
The Dalles 121
Los Angeles 118
Zgierz 117
Santa Clara 114
Tokyo 107
Beijing 106
Nanjing 98
Dallas 96
Medford 94
Ho Chi Minh City 92
Boardman 86
Frankfurt am Main 83
Des Moines 66
Brussels 65
Hefei 63
Princeton 62
Lauterbourg 61
Chicago 54
San Diego 54
Helsinki 53
Altamura 51
Hanoi 49
Dearborn 42
Lawrence 42
Tulsa 41
São Paulo 40
Ludwigshafen am Rhein 39
Buffalo 38
Jinan 33
Shenyang 33
Phoenix 30
Seoul 30
Kitzingen 29
London 29
Milan 28
Nanchang 27
Tianjin 27
Warsaw 27
Orem 26
Rome 26
Montreal 25
Munich 25
Seongnam 24
Venice 24
Changsha 23
Atlanta 21
Falls Church 21
Jiaxing 21
Brooklyn 19
Chennai 19
Columbus 18
Kumar 18
Bremen 17
Ningbo 16
Stockholm 16
Tehran 16
Guangzhou 15
Amsterdam 14
Haiphong 14
Nuremberg 14
Redwood City 14
Baghdad 13
Denver 13
Poplar 13
Saint Petersburg 13
Springfield 13
City of London 12
Hebei 12
Lancaster 12
Philadelphia 11
Rio de Janeiro 11
San Mateo 11
Auburn Hills 10
Boston 10
Brasília 10
Hangzhou 10
Hillsboro 10
Naples 10
San Francisco 10
San José 10
Shanghai 10
Toronto 10
Totale 9.270
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 444
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 371
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 352
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 339
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 338
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 326
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 323
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 322
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 314
A headlight on liquid biopsies: a challenging tool for breast cancer management 309
Founder mutations in BRCA1 and BRCA2 genes 307
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 298
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 294
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 293
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 290
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 289
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 285
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 283
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 278
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 278
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 278
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 277
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 277
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 272
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 267
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 266
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 262
Liquid Biopsy in Breast Cancer 260
A missense mutation associated to early onset breast cancer in a sicilian woman. 256
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 255
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 253
VUS variants in BRCA genes of hereditary breast/ovarian cancer 252
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 251
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 250
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 248
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 247
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 244
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 241
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 237
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 224
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 216
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) 214
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 213
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 211
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 210
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors 201
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) 190
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 189
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 189
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 188
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 187
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 183
RUOLO DI P53 E DEI GENI K-RAS ED H-RAS NELLA TUMORIGENESI DEI CARCINOMI DELLE GHIANDOLE SALIVARI 180
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 174
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 174
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 168
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 161
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 147
RUOLO DI P53 E DEI GENI K-RAS EDH-RAS NELLA TUMORIGENESI DELLE GHIANDOLE SALIVARI 145
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 141
TP53 mutations are not prognostic indipendent indicators in bladder cancer 139
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 116
null 25
Totale 15.411
Categoria #
all - tutte 45.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022600 0 0 0 39 43 37 66 41 87 101 57 129
2022/20231.123 117 202 20 148 138 161 54 85 132 9 42 15
2023/2024567 36 69 36 46 29 132 58 60 1 10 4 86
2024/20251.454 21 78 66 128 72 63 120 135 88 211 181 291
2025/20265.067 439 185 297 373 453 756 634 484 355 732 153 206
2026/2027993 224 140 627 2 0 0 0 0 0 0 0 0
Totale 15.411